MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

16 Nov 2023 Evaluate

Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting arranged by JP Morgan scheduled on 21st November 2023 at 05:30 pm to 06:30 pm at Hyderabad. The type of the meeting is In-person (investor group). No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1650.00 19.00 (1.16%)
28-Aug-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1922.35
Dr. Reddys Labs. 1174.70
Cipla 1416.80
Lupin 2171.05
Zydus Lifesciences 1174.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: